Levetiracetam Injection
Product Images NDC 72485-106

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 72485-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Carton (7248510610)

Levetiracetam Injection, USP is a medication that needs to be diluted prior to administration and is suitable for intravenous use. It is available in single-dose vials containing 500 mg of the active ingredient per 5 mL of solution. The product is identified by a product code and a national drug code.*

FDA Label Image

Fig 1 (Levitiracetamfigure1)

This appears to be a chart showing the percentage of patients and the effectiveness of two different dosages of Levetiracetam compared to a placebo for treating a medical condition. The dosage amounts are 1000mg/day and 3000mg/day. The chart shows that at the higher dosage, 39.6% of patients showed improvement, compared to 37.1% at the lower dosage, and only 7.4% for the placebo group. However, there is not enough context to determine what the medical condition being treated is.*

FDA Label Image

Fig 2 (Levitiracetamfigure2)

FDA Label Image

Fig 3 (Levitiracetamfigure3)

FDA Label Image

Fig 4 (Levitiracetamfigure4)

The given text represents the percentage of patients in a clinical trial who were either given a placebo or a medication called Levetiracetam. The percentages range from 0% to 44.6%. These percentages are grouped in intervals of 5% and are represented on a chart. The chart shows that 44.6% of patients were given Levetiracetam, while 19.6% were given a placebo. The remaining percentages are not specified.*

FDA Label Image

Fig 5 (Levitiracetamfigure5)

This appears to be a table comparing the effectiveness of a placebo versus a drug called Levetiracetam on a group of patients. The percentages seem to represent the proportion of patients who experienced some sort of benefit or improvement while taking either the placebo or the drug. However, without more context, it is difficult to determine what kind of benefit is being measured or in what kind of study this data was obtained.*

FDA Label Image

Fig 6 (Levitiracetamfigure6)

The text represents a table that compares the percentage of patients in a clinical trial who received a placebo (N=84) versus the percentage who received Levetiracetam (N=79). The table shows the percentage of patients at different levels of efficacy, ranging from 100% to 0%. However, the actual values for efficacy are not provided in the text.*

FDA Label Image

Structure (Levitiracetamstrc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.